Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 22.54%238.03M | -36.06%456.86M | -41.63%194.25M | -27.54%714.49M | -42.34%332.8M | -8.92%986.09M | 19.13%577.16M | 20.14%1.08B | 24.35%484.46M | -31.53%901.14M |
| Operating income | 22.54%238.03M | -36.06%456.86M | -41.63%194.25M | -27.54%714.49M | -42.34%332.8M | -8.92%986.09M | 19.13%577.16M | 20.14%1.08B | 24.35%484.46M | -31.53%901.14M |
| Cost of sales | -23.52%-147.39M | 24.97%-304.49M | 33.31%-119.33M | 29.97%-405.81M | 46.95%-178.93M | 9.55%-579.46M | -13.43%-337.29M | -16.49%-640.66M | -9.40%-297.37M | 35.11%-549.98M |
| Operating expenses | -23.52%-147.39M | 24.97%-304.49M | 33.31%-119.33M | 29.97%-405.81M | 46.95%-178.93M | 9.55%-579.46M | -13.43%-337.29M | -16.49%-640.66M | -9.40%-297.37M | 35.11%-549.98M |
| Gross profit | 20.96%90.63M | -50.64%152.37M | -51.31%74.93M | -24.09%308.68M | -35.86%153.87M | -8.00%406.64M | 28.21%239.88M | 25.86%441.98M | 58.83%187.1M | -25.05%351.16M |
| Selling expenses | 23.47%-58.87M | 6.73%-181.07M | -4.25%-76.93M | 0.58%-194.13M | 4.80%-73.8M | -11.84%-195.27M | -22.43%-77.52M | -10.78%-174.59M | 3.38%-63.31M | 21.48%-157.6M |
| Administrative expenses | 17.03%-65.73M | -2.47%-160.1M | -4.79%-79.23M | -1.46%-156.24M | 2.76%-75.6M | 0.12%-153.98M | -1.37%-77.75M | -21.87%-154.17M | 2.76%-76.7M | 16.74%-126.51M |
| Research and development expenses | 89.38%-1.12M | 81.88%-3.67M | 8.79%-10.59M | 1.88%-20.24M | -10.95%-11.61M | 4.20%-20.62M | 6.12%-10.46M | 6.64%-21.53M | -8.98%-11.14M | 13.55%-23.06M |
| Impairment and provision | ---- | -35.55%-94.89M | ---- | -932.57%-70M | ---- | 3.16%-6.78M | ---- | ---7M | ---- | ---- |
| -Impairment of intangible assets | ---- | 23.96%-41.82M | ---- | -711.33%-55M | ---- | 3.16%-6.78M | ---- | ---7M | ---- | ---- |
| -Impairment of property, machinery and equipment | ---- | -0.32%-13.04M | ---- | ---13M | ---- | ---- | ---- | ---- | ---- | ---- |
| -Other impairment is provision | ---- | -1,903.10%-40.02M | ---- | ---2M | ---- | ---- | ---- | ---- | ---- | ---- |
| Special items of operating profit | 180.28%26.69M | -57.20%15.88M | -0.67%9.52M | 634.54%37.1M | 2,642.97%9.59M | 23.90%-6.94M | 11.29%-377K | 69.30%-9.12M | -140.55%-425K | -139.61%-29.7M |
| Operating profit | 89.79%-8.41M | -186.29%-271.48M | -3,463.18%-82.3M | -511.58%-94.83M | -96.68%2.45M | -69.51%23.04M | 107.71%73.77M | 428.82%75.57M | 199.25%35.52M | -90.67%14.29M |
| Financing cost | -52.30%-3.24M | -17.68%-4.47M | -4.22%-2.13M | 12.03%-3.8M | 10.21%-2.04M | 7.14%-4.32M | -0.49%-2.27M | 13.16%-4.65M | 23.92%-2.26M | 8.69%-5.36M |
| Earning before tax | 86.21%-11.64M | -179.79%-275.95M | -20,842.75%-84.42M | -626.89%-98.63M | -99.43%407K | -73.60%18.72M | 115.00%71.5M | 693.95%70.92M | 185.81%33.26M | -93.94%8.93M |
| Tax | -136.46%-227K | -428.32%-22.78M | -380.00%-96K | 74.47%-4.31M | 91.03%-20K | -3.74%-16.89M | -54.86%-223K | -1,629.97%-16.28M | -3.60%-144K | 87.98%-941K |
| After-tax profit from continuing operations | 85.95%-11.87M | -190.20%-298.73M | -21,939.53%-84.52M | -5,722.06%-102.94M | -99.46%387K | -96.65%1.83M | 115.26%71.28M | 583.73%54.64M | 185.13%33.11M | -94.27%7.99M |
| Earning after tax | 85.95%-11.87M | -190.20%-298.73M | -21,939.53%-84.52M | -5,722.06%-102.94M | -99.46%387K | -96.65%1.83M | 115.26%71.28M | 583.73%54.64M | 185.13%33.11M | -94.27%7.99M |
| Minority profit | 172.21%369K | 52.98%-158K | -1,792.59%-511K | 92.36%-336K | 96.25%-27K | -866.37%-4.4M | -220.00%-720K | 82.48%-455K | 87.41%-225K | 25.93%-2.6M |
| Profit attributable to shareholders | 85.43%-12.24M | -191.00%-298.57M | -20,391.79%-84.01M | -1,747.46%-102.6M | -99.42%414K | -88.70%6.23M | 115.97%72M | 420.32%55.09M | 189.84%33.34M | -92.60%10.59M |
| Basic earnings per share | 85.42%-0.0162 | -190.44%-0.395 | -22,320.00%-0.1111 | -1,800.00%-0.136 | -99.47%0.0005 | -89.04%0.008 | 138.00%0.0952 | 630.00%0.073 | 180.00%0.04 | -94.74%0.01 |
| Diluted earnings per share | 85.42%-0.0162 | -190.44%-0.395 | -22,320.00%-0.1111 | -1,800.00%-0.136 | -99.47%0.0005 | -89.04%0.008 | 138.00%0.0952 | 630.00%0.073 | 180.00%0.04 | -94.74%0.01 |
| Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | -- | -- | -- | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | Guofu Haohua (Hong Kong) Certified Public Accountants Limited | -- | Rosenmei Certified Public Accountants | -- | Luo Shenmei Accounting Firm | -- | Rosenmei Certified Public Accountants | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.